BlueKey Equity Partners Invests in ICHOR Vascular, Inc

May 02, 2023

BlueKey Equity Partners Invests in ICHOR Vascular, Inc. to Revolutionize Treatment for Peripheral Vascular Occlusions


FOR IMMEDIATE RELEASE


Hollywood, Fla. – May 2, 2023 -  - BlueKey Equity Partners (BKEP), a leading investment firm specializing in small and mid-capital growth companies, is proud to announce its recent investment in ICHOR Vascular, Inc., based in Boca Raton, Fla.

ICHOR is a cutting-edge medical device company focused on developing innovative solutions for treating peripheral vascular occlusions. The investment will support ICHOR's vision to become the first line on the table therapy for physicians and hospitals by offering a versatile solution aimed at rapid reperfusion without the need for surgery or thrombolytic drug therapies.

ICHOR Vascular, Inc. has developed a groundbreaking 7F arterial and 14F venous percutaneous reperfusion system that offers clinical flexibility and incorporates a health economic element. 

“This ‘one size fits all’ system replicates successful parameters of surgical clot removal and provides physicians with a versatile tool to treat a wide range of vascular occlusions ranging from 2mm to 18mm vessels, said Timothy S. Blair, President and Chief Marketing Officer of ICHOR. “Unlike current options such as surgery, drug therapy, or borrowed technologies, ICHOR's innovative approach brings the vascular occlusions to the catheter with a tried-and-true balloon technique, making it a much-needed technology for treating peripheral arterial disease (PAD) in the lower limbs.”

Peripheral vascular occlusions are a significant yet less studied or understood condition compared to stroke or coronary disease. However, arterial and venous disease of the lower limbs is a large and fast-growing market with significant mortality rates. Current treatment options lack flexibility and broad utility, resulting in suboptimal outcomes and increasing costs. ICHOR's technology aims to disrupt the status quo and become the go-to device for physicians and hospitals seeking conclusive therapy with a design that is both elegant and intuitive.

"We believe that ICHOR Vascular, Inc. has the potential to revolutionize the treatment of peripheral vascular occlusions," said Amaury Cifuentes, CFP®, CMP®, and a BlueKey Equity Partner. "Their innovative approach and versatile solution have the potential to offer significant benefits to patients, physicians, and hospitals, and we are excited to support their mission."

###


About ICHOR Vascular, Inc. 

Located in Boca Raton, Fla., ICHOR is a medical device company that has developed a 7F (510k) arterial and a 14F venous percutaneous reperfusion system which offers versatility to treat a wide range of vascular occlusions (2mm – 18mm vessels).  A one size fits all system that replicates successful parameters of surgical clot removal. The technology gives physicians clinical flexibility and incorporates a health economic element that will make ICHOR a 1st line on the table therapy for physicians and hospitals.


About BlueKey Equity Partners 

BlueKey Equity Partners is a private investment firm specializing in small and mid-capital growth companies. With a focus on private lending, core real estate, and business investment, BlueKey Equity Partners leverages partnerships between investors, principals, and communities to provide capital, innovative solutions, and strategic expertise to its portfolio throughout the investment cycle.


Media Contact: Julie Spechler for BlueKey Equity Partners l Phone: (954) 401-1425 l Email: juliespechler@gmail.com´╗┐


Read the full article HERE´╗┐